COVID-19 Vaccination of Individuals with Down Syndrome—Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated

Individuals with Down syndrome (DS) are among the groups with the highest risk for severe COVID-19. Better understanding of the efficacy and risks of COVID-19 vaccines for individuals with DS may help improve uptake of vaccination. The T21RS COVID-19 Initiative launched an international survey to ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Hüls, Anke, Feany, Patrick T., Zisman, Sophia Isabella, Costa, Alberto C. S., Dierssen, Mara, Balogh, Robert, Bargagna, Stefania, Baumer, Nicole T., Brandão, Ana Claudia, Carfi, Angelo, Chicoine, Brian Allen, Ghosh, Sujay, Lakhanpaul, Monica, Levin, Johannes, Lunsky, Yona, Manso, Coral, Okun, Eitan, Real de Asua, Diego, Rebillat, Anne-Sophie, Rohrer, Tilman R., Sgandurra, Giuseppina, Valentini, Diletta, Sherman, Stephanie L., Strydom, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030605/
https://www.ncbi.nlm.nih.gov/pubmed/35455279
http://dx.doi.org/10.3390/vaccines10040530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030605/
https://www.ncbi.nlm.nih.gov/pubmed/35455279
http://dx.doi.org/10.3390/vaccines10040530

Ejemplares similares